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Edited by Aleksander BenjakAbstract We investigated the role of microRNAs (miRNA) in
protection against ischemia/reperfusion (I/R) injury in heart.
Mice subjected to cytoprotective heat-shock (HS) showed a sig-
niﬁcant increase of miRNA-1, miRNA-21 and miRNA-24 in the
heart. miRNAs isolated from HS mice and injected into non-HS
mice signiﬁcantly reduced infarct size after I/R injury, which was
associated with the inhibition of pro-apoptotic genes and increase
in anti-apoptotic genes. Chemically synthesized miRNA-21 also
reduced infarct size, whereas a miRNA-21 inhibitor abolished
this eﬀect. Overall, these studies for the ﬁrst time provide
evidence for the potential role of endogenously synthesized
miRNAs in cardioprotection following I/R injury.
 2008 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Apoptosis1. Introduction
MicroRNAs (miRNAs) are family of small regulatory mol-
ecules that function by modulating protein production. There
are approximately 500 known mammalian miRNA genes, and
each miRNA may regulate hundreds of diﬀerent protein-cod-
ing genes. miRNA biogenesis starts in the nucleus where miR-
NA is transcribed by RNA polymerase II to generate long
primary transcripts (pri-miRNA). The pri-miRNA is trimmed
by RNase III type enzyme drosha to release the hairpin inter-
mediates (pre-miRNA). The pre-miRNA is then exported to
the cytoplasm by expotin-5 where they are subjected to the sec-
ond processing by Dicer, the cytoplasmic RNase III type en-
zyme. The pre-miRNA is cleaved into the short-lived
miRNA duplex, whose one strand is degraded by an unknown
nuclease while the other strand remains as a mature miRNA
[1–5]. Binding with miRNAs in the cytoplasm is responsible
for negative regulation of the target either through degrada-
tion of the bound mRNA or by inhibition of its translation
[6]. Therefore, up-regulation of miRNAs leads to decreased
gene expression. However, they can also lead to up-regulation
of proteins by negatively modulating the expression of inhibi-
tory genes.
Recent studies suggest that miRNA participate in many cel-
lular processes, such as apoptosis [7–9], fat metabolism [10],
cell diﬀerentiation [11–13], tumorigenesis [14] and cardiogene-*Corresponding author. Fax: +1 804 828 870.
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doi:10.1016/j.febslet.2008.11.014sis [15–19]. miRNAs are also critically involved in the patho-
logical process of adult hearts, including cardiac hypertrophy
[20–23], heart failure [24], angiogenesis [25] and arrhythmogen-
esis [26]. However, the potential role of endogenously synthe-
sized miRNAs in attenuation of myocardial ischemia/
reperfusion injury by well-established endogenous therapeutic
has never been studied.
It has been shown that exposing hearts to stresses such as
sub-lethal ischemia or mild heat-shock improves myocardial
survival after subsequent prolonged ischemia/reperfusion in-
jury [27–29]. Molecular chaperones that are rapidly synthe-
sized and deployed to prevent protein misfolding and to
assist in their refolding to the native state [30]. A set of genes
and signaling pathways involved in heat-shock-induced protec-
tion have been proposed [31,32]. However, the regulation of
cardioprotection following heat-shock at the pretranslational
level has never been investigated. In the present study, we
tested the hypothesis that miRNA may play an important role
in protection against ischemia/reperfusion injury in the heart.
We induced endogenous miRNA through heat-shock and in-
jected them into non-heat-shocked mice. This experimental de-
sign took advantage of testing the role of miRNA using the
animals own endogenously induced miRNA in vivo. Our re-
sults show that miRNA reproduced heat-shock like protection
against ischemia/reperfusion injury in the non-heat-shocked
mice, apparently through mechanisms involving repression of
apoptotic genes and upregulating anti-apoptotic genes.2. Materials and methods
2.1. Animals
Adult outbred ICR mice from Harlan (Indianapolis, Indiana) were
used and the guidelines on humane use and care of laboratory animals
for biomedical research published by NIH (No. 85-23, revised 1996)
were strictly complied for all animal experiments.
2.2. miRNA induction
The mouse was anaesthetized with sodium pentobarbital (50 mg/kg
body weight, i.p.). Approximately 10 min after the injection, the ani-
mal was placed on an electric heating pad which was folded to cover
up the whole body except head. A small diameter rectal thermal probe
(YSI-402) was inserted into the animals colon (about 1 cm) to record
the core body temperature. The animals were then subjected to heat-
shock by raining the temperature to 42 C for 15 min. Animals in
the sham control groups received identical treatment except their body
temperature was not raised. After their recovery at room temperature
for 2 h, the hearts and livers were removed for isolation of miRNA.
Since whole body heat-shock also aﬀects liver in terms of the synthesis
of heat-shock proteins and inducing ischemic tolerance [48], we used
both liver as well as heart for extraction of miRNAs in order to have
suﬃcient amount of miRNA for in vivo treatments.ation of European Biochemical Societies.
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miRNA was isolated from the hearts of both heat-shocked and non-
heat-shocked mice using a miRNA Isolation Kit from Ambion
(Austin, TX, USA). The isolation method combines the chemical
and solid phase extraction techniques to obtain optimal miRNA.
The isolated miRNA was treated with DNase to eliminate DNA con-
tamination (DNA-free, Ambion) and conﬁrmed by RT-PCR using
speciﬁc primers to miRNA 1, 21 and 24 (Ambion). RT-PCR was per-
formed using Ambions miRNA Detection Kit. The RT-PCR ampli-
ﬁed miRNA was visualized on 3.5% high resolution agarose gel and
measured by densitometer. miRNA signals from both treated and
non-treated mice were normalized by GAPDH from the same samples
to eliminate loading error.
2.4. miRNA treatment
Prior to injection, the isolated miRNAs were incubated in polyamine
solution at 22 C for 30 min to form miRNA–amine complexes [49].
The complex containing 40 lg miRNA was then injected intraperitone-
ally into the non-heat-shocked mice. To verify the speciﬁc role of miR-
NAs, a group of mice were treated with chemically synthesized
miRNA-21 to reproduce the results obtained by utilizing heat-
shock-induced miRNAs. Another sub-set of mice were treated with
miRNA-21 with and without antisense miRNA-21 to see if the infarct
limiting eﬀect of miRNA-21 is abolished. The modiﬁed antisense oligo-
nucleotide (2 0OMe-miR-21), also called miRNA inhibitor [50], had the
following sequence and structure: 5 0-mUmCmAmAmCmAmUmCm-
AmGmUmCmU–mGmAmUmAmAmGmCmA-3 0.
2.5. Langendorﬀ isolated perfused heart preparation
Twenty-four hours after miRNA injection, the animals were re-anes-
thetized with sodium pentobartital (100 mg/kg with 33 IU heparin,
i.p.). The heart was then removed quickly from the thorax and
dropped into a small dish containing ice-cold Krebs–Henseleit solution
with heparin. Under an illuminated magniﬁer, the aortic opening of
mouse heart was immediately cannulated and tied on a 20 gauge stain-
less steel blunt needle which was connected to a perfusion system in
Langendorﬀ mode. Hearts were retrogradely perfused with a modiﬁed
Krebs–Henseleit solution (contained NaCl 118, NaHCO3 24, CaCl2
2.5, KCl 4.7, KH2PO4 1.2, MgSO4 1.2, Glucose 11, EDTA 0.5, in
mM; gassed with 95% O2 + 5% CO2; pH 7.39–7.42) at a constant pres-
sure of 55 mmHg. The perfusion solution was warmed through a
water-jacketed glass cylinder/heat exchanger system and the tempera-
ture was monitored continuously by a thermocouple thermometer
(COLE-PALMER, Model 8112-10) with a Type K micro-probe and
maintained at 37 ± 0.2 C throughout the experiment. Hearts were
subjected to 20 min of global ischemia followed by reperfusion fro
30 min. At the end of reperfusion, the heart was immediately removed
from the Langendorﬀ apparatus, weighed and frozen at 20 C. The
frozen heart was cut into six to seven transverse slices, stained by
10% tetrazolium chloride for 30 min at room temperature (22 C)Co
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Fig. 1. Induction of miRNA following heat-shock in mice. (A) RT-PCR pro
Statistical analysis of miRNA following heat-shock. Data are normalized ﬁrs
and extracted 2-h later. The extracted miRNA was reverse transcribed int
condition used was: 30 cycles of 94 C/30 s, 55 C/30 s and 72 C/30 s.and subsequently ﬁxed with 10% formalin for 2–4 h. The infarct area
and risk zone was measured using computer morphometry (Bioquant
98). The risk area was calculated as total ventricular area minus the
area of the cavities. The infarct size was presented as percentage of
the risk area.
2.6. Gene microarray analysis
Eﬀect of miRNA treatment on apoptotic genes was assessed using
cDNA array containing 112 key genes involved in apoptosis. Total
RNA from both miRNA injected and control mouse hearts was iso-
lated and incubated with DNase to eliminate DNA contamination.
Thereafter, mRNA was reverse transcribed, labeled with biotin-
UTP, hybridized with the array as described by Superarray Biosci-
ence Corporation (Fredrick, MD, USA). The hybridized signal was
detected using Chemiluminescent Detection Kit from the same com-
pany.
2.7. Data analysis and statistics
All data were normalized by their corresponding control and pre-
sented as the group means ± S.E.M. The diﬀerence among experimen-
tal groups was compared by unpaired t-test or one-way ANOVA
followed by Student–Newman–Keuls post-hoc test. P < 0.05 was con-
sidered as statistically signiﬁcant.3. Results
3.1. miRNA induction
Mice subjected to heat-shock showed induction in miRNA
as compared to the non-heat-shocked control. The miRNA
induction was veriﬁed using RT-PCR which detected signiﬁ-
cant increases in miRNA-1 (78%), miRNA-21 (103%) and
miRNA-24 (61%) in the heart as shown in Fig. 1. However,
only miRNA-1 was veriﬁed in the liver (not shown) although
a number of other miRNAs may have been induced as well.
3.2. Infarct size
Mice treated with the mixture of miRNA isolated from
heat-shocked mice demonstrated improved ischemic toler-
ance. Infarct size was reduced signiﬁcantly e from 40 ± 2.7
(percentage of total risk area, mean ± S.E.M.) in the non-
heat-shocked controls to 18.5 ± 3.8 in mice treated with the
miRNA (Fig. 2). Moreover, chemically synthesized exogenous
miRNA-21 also reduced infarct size by 64% (P < 0.05 versus
control). The miRNA-21 induced protection was totallyNA-1 miRNA-21 miRNA-24
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42oC
* * *
0.05 vs. Control, n = 3
*
ducts of miRNA were visualized in 3% high resolution agarose gel. (B)
t by GAPDH and then by control. miRNA was induced by heat-shock
o cDNA and ampliﬁed using PCR-primers from Ambion. The PCR
Ca
spa
se 
1
Ca
spa
se
 
2
Ca
spa
se 
8
Ca
spa
se 
14
0.0
0.5
1.0
1.5 Control
miRNA
* *
*
*
m
R
N
A
   
Le
v
el
*
p<0.05 vs. Control,  n = 3
Bid
Bc
l-1
0
Cid
ea
Lt
br
Tr
p5
3
Fa
s
Fa
sl
0.00
0.25
0.50
0.75
1.00
1.25
1.50
Control
miRNA
*
*
*
* * *
*
*
p<0.05 vs. Control,  n = 3
m
R
N
A
   
Le
ve
l
Ba
g3
Bn
ip3
Prd
x2
0
1
2
3
4
5
miRNA
Control
*
*
*
m
R
N
A
 
 
 
Le
v
el
*
p<0.05 vs. Control,  n = 3
A
B
C
Fig. 3. Eﬀect of miRNA treatment on apoptotic genes. (A) miRNA
treated hearts demonstrated a depressed expression of caspase family
members. (B) Except for Bnip-3miRNA treatment suppressed expres-
sion of several pro-apoptotic genes. (C) Increase in anti-apoptotic
genes in the heart in miRNA treatment mice. Total RNA was
extracted 4-h after miRNA injection and incubated with DNase to
eliminate DNA contamination. The puriﬁed total RNA was then
labeled and hybridized to apoptosis gene arrays following manufac-
turers manual.
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Fig. 2. Eﬀect of miRNA-21 and its inhibitor on cardiac infarct size
following ischemia/reperfusion. Top: bar diagram showing a signiﬁ-
cant reduction of infarct size compared to the non-treated controls.
Chemically synthesized miRNA-21 also reduced infarct size signiﬁ-
cantly. The miRNA induced infarct size reduction was completely
abolished by miRNA-21 inhibitor. Bottom: representative images of
mouse heart slices stained with 10% of triphenyl tetrazolium chloride
(TTC). Heart samples were selected from the following experimental
groups: Control, miRNAs, miRNA-21 and miRNA-21 inhibitor. Note
that infarct area is signiﬁcantly larger (as shown by the increased pale
areas) in the control and miRNA-21 inhibitor treated mice as
compared to the miRNAs and miRNA-21 groups. The hearts were
subjected to 20 min of global ischemia and 30 min of reperfusion 24-h
following miRNA injection. Infarct size was measured at the end of
ischemia–reperfusion using tetrazolium staining.
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inhibitor.
3.3. miRNA and apoptosis
miRNA treatment caused profound changes in several apop-
totic related genes as determined by gene microarray analysis.
As shown in Fig. 3A, the caspase family members 1, 2, 8 and
14 were suppressed in the hearts treated with miRNA from
heat-shock mice as compared to the controls. Except for
BNIP-3, most of the pro-apoptotic genes including Bid (BH3
interacting domain death agonist), Bcl-10 (B-cell leukemia/
lymphoma 10), Cidea (cell death-inducing DNA fragmenta-
tion factor, alpha subunit-like eﬀector A), Ltbr (lymphotoxin
B receptor), Trp53 (transformation related protein 53), Fas
(TNF receptor superfamily member) and Fasl (Fas ligand,
TNF superfamily, member 6), were also repressed (Fig. 3C).
On the other hand, the anti-apoptotic genes, Bag-3 (Bcl-2-
associated athanogene and Prdx2 (Peroxiredoxin 2) were in-
creased (Fig. 3C).4. Discussion
Several studies have shown that heat-shock treatment pro-
tects the heart against ischemia/reperfusion injury [33]. The
speciﬁc mechanisms underlying heat-shock protection include
synthesis of heat-shock proteins [34], antioxidant defenses[35], and enhanced mitochondrial respiration [36]. In addition,
it has been shown that heat-shock protects by opening of mito-
chondrial KATP channels [37] and causes resistance to opening
of mitochondrial permeability transition pore [38], which may
contribute to heat-shock protection against cellular injury
through inhibition of apoptosis. In the present study, we have
observed a signiﬁcant induction of miRNA-1, miRNA-21 and
miRNA-24 following whole body heat-shock in the heart.
Moreover, mice treated with miRNAs isolated from the
heat-shocked mice demonstrated signiﬁcantly reduced infarct
size in the heart following global ischemia and reperfusion.
4140 C. Yin et al. / FEBS Letters 582 (2008) 4137–4142Similarly, injection of chemically synthesized exogenous miR-
NA-21 reduced infarct size and the co-treatment with the 2 0-
O-methyl miRNA – which blocks miRNA-21 through anti-
sense inhibition abolished the protective eﬀect. Except for
Bnip-3, miRNA injection caused downregulation of pro-apop-
totic proteins including caspases 1, 2, 8 and 14, Bid, Bcl-10, Ci-
dea, Ltbr, Trp53 and Fasl, while anti-apoptotic proteins
including Bag-3, and Prdx2 were increased. These results sug-
gest a potential role of miRNAs in reducing myocardial infarc-
tion through repression of apoptotic genes and up-regulation
of anti-apoptotic proteins.
Although only three miRNA, namely miRNA-1, 21 and 24,
were veriﬁed in the present study, heat-shock may well induce
many other miRNAs. We did not perform experiments to
demonstrate whether these intraperitoneally injected miRNAs
ended up in the heart. Nevertheless, a recent study showed that
the simple systemic delivery of a unconjugated locked-nucleic-
acid-modiﬁed oligonucleotide (LNA-antimiR) eﬀectively
antagonized the liver-expressed miRNA-122 [39]. Acute
administration by intravenous injections of LNA-antimiR in
monkeys resulted in uptake of the LNA-antimiR in the cyto-
plasm of primate hepatocytes and formation of stable hetero-
duplexes between the antimiR and miRNA-122. This was
accompanied by depletion of mature miRNA-122 and dose-
dependent lowering of plasma cholesterol. Our data also sup-
ports these ﬁndings because the chemically synthesized miR-
NA-21 reduced infarct size in the heart which was blocked
with miRNA-21 inhibitor. These data suggest the possibility
that the physiological eﬀect of the miRNA-21 and its antago-
nist were actually occurring in the heart following intraperito-
neal injection.
Apoptosis is a major cause for cardiac infarction following
ischemia–reperfusion [40,41]. miRNA-1 is preferentially ex-
pressed in cardiac muscle [42] and has been shown to regulate
apoptosis. The inhibition of miRNA-21 has been shown to
suppress cell growth by increasing apoptosis and decreasing
cell proliferation [43]. In contrast, knockdown of miR-21 in
cultured glioblastoma cells triggers activation of caspases
and leads to increased apoptotic cell death [7]. miRNA-24
has recently been shown to be involved in the inhibition of
skeletal muscle diﬀerentiation by TGF-b which provides clues
for mechanisms underlying the physiological roles of the
growth factor during myogenesis [44]. The attenuation of myo-
cardial infarction with miRNA in this study may be related to
reduced expression of apoptotic genes, Bid and Bcl-10 which
may account for the observed protection since increased Bid
and Bcl-10 can bind to Bcl-2 to promote apoptosis. On the
other hand, Bag-3 may compete with Bid and Bcl-10 to bind
to Bcl-2 to reduce apoptosis [45]. miRNA induction may also
reduce infarct size through additional cellular processes other
than apoptosis. For example, the increased levels of Prx2
observed in the current study may protect heart against oxida-
tive stress since Prx2 is an extremely eﬃcient scavenger of
hydrogen peroxide [46].
In this study, Bnip-3 was increased in the heart following
miRNA treatment. Although it is well recognized to be an
apoptotic gene, some studies suggest that BNIP-3 is not suﬃ-
cient for cell death but rather plays a critical role in hypoxia-
induced autophagy [47]. Moreover, it has been suggested that
rather than promoting death, BNIP-3 may actually allow sur-
vival either by preventing ATP depletion or by eliminating
damaged mitochondria [47]. Such a function of BNIP-3 maybe subverted under conditions associated with acidosis that
arise following extended periods of hypoxia and anaerobic gly-
colysis. Bnip-3 is also shown to be expressed in healthy adult
heart without evidence of cell death [48]. This ﬁnding is in line
with the study by Tracy and Macleod, who found that Bnip-3
allowed cells to survive by preventing ATP depletion or by
eliminating damaged mitochondria [47]. Overexpression of
Bnip-3 in HL-1 cardiac myocytes subjected to simulated ische-
mia/reperfusion, caused up-regulation of autophagic activity
which constituted a protective response against Bnip-3-medi-
ated death signaling [49].
In conclusion, for the ﬁrst time, we have provided evidence
for the potential role of endogenously synthesized miRNAs
in cardioprotection following ischemia/reperfusion injury.
These miRNA have many advantages over other exogenous
agents. For example, they are natural cellular products and
therefore, non-toxic to cells. They can be induced in vivo under
natural conditions, such as hyperthermia. Due to their short
length, miRNAs can also easy to move around and cross
sub-cellular structures. Therefore, identifying the role of
endogenously synthesized miRNAs in protective pathophysio-
logical stimuli including ischemic, heat-shock and by pharma-
cological preconditioning means may open up novel strategies
to protect the heart in patients with coronary artery disease.
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